Applied DNA Sciences (NASDAQ: APDN) reported Q4 EPS of ($0.60), $0.23 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $3 million versus the consensus estimate of $2.3 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.